Machine learning brings cell imaging promises into focus

Recursion, Janssen, insitro and others are combining high-content phenotypic screening with machine learning to zoom in on emerging opportunities in target discovery, hit identification, toxicity testing and more.

Search for this author in:

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Reviews Drug Discovery 18, 653-655 (2019)

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.